pancreatic cancer ERYTECH Pharma

ERYTECH Pharma enrols first patients in Phase lll trial of eryaspase

ERYTECH Pharma has enrolled the first three patients in the TRYbeCA1 trial, a Phase lll clinical study investigating eryaspase for…